Peer Review History

Original SubmissionOctober 29, 2022
Decision Letter - Wenguo Cui, Editor

PONE-D-22-29837Complications of biliary stenting versus T-tube insertion after common bile duct exploration: A systematic review and meta-analysisPLOS ONE

Dear Dr. Reno Rudiman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by January 12, 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wenguo Cui, Ph.D

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Author reviewed and did meta-analysis of 16 papers. These papers are published between 2004 – 2022 include 1,080 patients' (534 biliary stents and 546 T-tube) outcome of biliary stenting or T-tube insertion after common bile duct exploration operation. Author statistically analyzed the major complications rates, operation time, hospital stay length, etc. And author concluded stenting as biliary drainage after CBDE was superior to T-tube insertion.

Although the manuscript is drafted well and technically sounded good. The two candidates are just not comparable. Modern surgery are tend to be as less invasive as possible. While author also mentioned T-tube insertion already been dropped off by many places in the world and sooner or later it will not be used at all. On the other hand, the developing of stenting technology never stopped, stent itself even can be drug loaded or biodegradable.

Reviewer #2: This research article by Rudiman et al compared post T-tube or stent insertion with respect to procedure complications, efficacies and efficiencies. The authors analyzed 534 biliary stents and 546 T-tube patients and results showed that stenting after common bile duct exploration (CBDE) is superior to T-tube insertion with shorter operation time and hospital state as well as lower overall postoperative complication rate.

I believe that this manuscript is suitable for publication in Plos One. However, there are still some minor points that the authors need to address

1. all figures appear to be very blurry. Please upload high res figures.

2. It would be very informative to include more background information of stent and T-tube insertions in general.

2. Some sentences need to be described more clearly, for example, Page 16, “Thus, indicating no publication bias in this study…”, there was no subject in this sentence.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Review report_TuoYang.docx
Revision 1

Dear Editor-in-Chief of PLoS ONE,

Thank you for allowing us to submit a revised draft of our manuscript. We appreciate the time and effort you and the reviewers have dedicated to providing your valuable feedback on our manuscript. We are grateful to the reviewers for their insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided by the reviewers.

Here is a point-by-point response to the reviewers’ comments and concerns.

Reviewer 1

Author reviewed and did meta-analysis of 16 papers. These papers are published between 2004 – 2022 include 1,080 patients' (534 biliary stents and 546 T-tube) outcome of biliary stenting or T-tube insertion after common bile duct exploration operation. Author statistically analyzed the major complications rates, operation time, hospital stay length, etc. And author concluded stenting as biliary drainage after CBDE was superior to T-tube insertion.

Although the manuscript is drafted well and technically sounded good. The two candidates are just not comparable. Modern surgery are tend to be as less invasive as possible. While author also mentioned T-tube insertion already been dropped off by many places in the world and sooner or later it will not be used at all. On the other hand, the developing of stenting technology never stopped, stent itself even can be drug loaded or biodegradable.

Author’s comment: Thank you for your insightful comment. We agree that a less invasive approach has been a favorable technique in modern surgery. T-tube should be dropped off and shifted to minimally invasive method. Through this study, we would like to emphasize to the readers that biliary stent should be the preferred method due to its superiority in several aspects (shorter operation time, shorter hospital stay, and lower overall complications rate). The development of biliary stents has been quite remarkable in the last decade; however, these two candidates are feasible to be compared because in the last five years, our included studies still compared both methods and the limitation of healthcare services in developing countries force surgeons to choose T-tube as the initial option. With all deliberation, T-tube remains a realistic possibility without increasing patients’ mortality and morbidity in developing countries.

We also incorporated further reasons on writing this manuscript in the Discussion section.

Reviewer 2

1. All figures appear to be very blurry. Please upload high res figures.

Author’s comment: We have updated all figures using Prelight Analysis and Conversion Engine (PACE) digital diagnostic tool to ensure all figures meet PLOS requirements.

2. It would be very informative to include more background information of stent and T-tube insertions in general.

Author’s comment: Thank you for your consideration. In the Introduction section, we have incorporated additional background information on biliary stent and T-tube.

3. Some sentences need to be described more clearly, for example, Page 16, “Thus, indicating no publication bias in this study…”, there was no subject in this sentence.

Author’s comment: Thank you for your valuable feedback. We have completed that sentence.

We look forward to hearing from you in due time regarding the submission, responses, further questions, and comments you may have.

Sincerely,

Reno Rudiman

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Wenguo Cui, Editor

PONE-D-22-29837R1Complications of biliary stenting versus T-tube insertion after common bile duct exploration: A systematic review and meta-analysisPLOS ONE

Dear Dr. Reno Rudiman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by January 15, 2023.  If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wenguo Cui, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this revision, author added more back ground information about T-tube insertion procedure and author also added explanation about how T- tube insertion compare to biliary stenting in discussion section. Manuscript is getting better but there are still have few more things I think author should make it more clear:

Author referred PRISMA guideline but Review Manager software has been used for conducting meta-analysis. Therefore, beside "The PRISMA flowchart of the studies selection process", how the Review Manager been configured and handled should be described in details since most of the data are generated by the Review Manager software in this paper.

Also, since this is a scientific paper doing meta-analysis. Statistical analysis in "Method" section should be explained with a lot more details. The manuscript mentioned 4 formulas in total. Please elaborate: Is there any result from PICOS formula? What is Mantel-Haenszel formula with random-effect models to calculate RR and CI? And what is Inverse-Variance formula with random-effect models that was used to assess the SMD and SD? Although formula to convert means

and standard deviations (SD) for meta-analysis data synthesis has a reference. How this formular been used in this manuscript needs more explanation.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Dear Editor-in-Chief of PLoS ONE,

Thank you for allowing us to submit a revised draft of our manuscript. We appreciate the time and effort you and the reviewers have dedicated to providing your valuable feedback on our manuscript. We are grateful to the reviewers for their insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided by the reviewers.

Here is a point-by-point response to the reviewer’ comments and concerns.

Reviewer 1

Reviewer #1: In this revision, author added more back ground information about T-tube insertion procedure and author also added explanation about how T- tube insertion compare to biliary stenting in discussion section. Manuscript is getting better but there are still have few more things I think author should make it more clear: Author referred PRISMA guideline but Review Manager software has been used for conducting meta-analysis. Therefore, beside "The PRISMA flowchart of the studies selection process", how the Review Manager been configured and handled should be described in details since most of the data are generated by the Review Manager software in this paper. Also, since this is a scientific paper doing meta-analysis. Statistical analysis in "Method" section should be explained with a lot more details. The manuscript mentioned 4 formulas in total. Please elaborate: Is there any result from PICOS formula? What is Mantel-Haenszel formula with random-effect models to calculate RR and CI? And what is Inverse-Variance formula with random-effect models that was used to assess the SMD and SD? Although formula to convert means and standard deviations (SD) for meta-analysis data synthesis has a reference. How this formular been used in this manuscript needs more explanation.

Author’s comment: Thank you for your insightful suggestion.

1. Yes, there is a result from the PICOS formula, which we have elaborated in the Result Section and all the outcomes were statistically analysed

2. We have described further the Mantel-Haenszel and Inverse-Variance formula in the Synthesis Methods Section.

We look forward to hearing from you regarding the submission, responses, questions, and comments you may have.

Sincerely,

Reno Rudiman

Attachments
Attachment
Submitted filename: Response to Reviewer.docx
Decision Letter - Wenguo Cui, Editor

Complications of biliary stenting versus T-tube insertion after common bile duct exploration: A systematic review and meta-analysis

PONE-D-22-29837R2

Dear Dr. Reno Rudiman,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wenguo Cui, Ph.D

Academic Editor

PLOS ONE

Formally Accepted
Acceptance Letter - Wenguo Cui, Editor

PONE-D-22-29837R2

Complications of biliary stenting versus T-tube insertion after common bile duct exploration: A systematic review and meta-analysis

Dear Dr. Rudiman:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Wenguo Cui

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .